PRECIDENTD (PREvention of CardIovascular and DiabEtic kidNey disease in Type 2 Diabetes)
PREvention of CardIovascular and Diabetic Kidney Disease in Type 2 Diabetes (PRECIDENTD)
Sponsor: PCORI
Enrolling: Male and Female Patients
Study Length: 5 Years
Clinic Visits: 9
IRB Number: AAAU2891
U.S. Govt. ID: NCT05390892
Contact: Anabel Evans: 212-851-5492 / ae2816@cumc.columbia.edu
Additional Study Information: In PRECIDENTD, we hope to learn which diabetes medications work best to reduce the risk of heart and kidney disease in people with type 2 diabetes. People with type 2 diabetes are twice as likely to have heart disease or a stroke compared to someone who does not have diabetes, and they are likely to have heart disease or stroke at a younger age. People with type 2 diabetes and heart disease, stroke, or other vascular (blood vessel) disease or who have high risk for these can participate in the study. If you enroll in PRECIDENTD, you will: Be prescribed a diabetes medication that reduces the risk of heart disease in addition to lowering blood glucose and weight; attend annual visits in-person or via telemedicine and complete questionnaires every 6 months for up to 8 years; share your health information to help answer one of the most pressing questions in how to take care of people with type 2 diabetes; receive $500 per year.
Investigator
Jacqueline Lonier, MD
Do You Qualify?
Have you been diagnosed with type 2 diabetes? Yes No
Are you between the ages of 40 and 80? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.


For more information, please contact:
Anabel Evans
ae2816@cumc.columbia.edu
212-851-5492